Despite a shrinking asset base that has contracted over $12 billion from its peak to $116.0B, a debt-to-equity ratio of 0.29 suggests ample capitalization, though this may reflect asset runoff rather than proactive growth.
Aflac Incorporated (AFL) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Assets | 115.96B | 116.47B | 117.57B | 126.72B | 131.74B | 157.54B | 165.09B | 152.77B | 140.41B | 137.22B | 129.82B | 118.26B | 119.77B | 121.31B | 131.09B | 116.24B | 101.04B | 84.11B | 79.33B | 65.81B | 59.8B | 56.36B | 59.33B | 50.96B | 45.06B | 37.86B | 37.23B | 37.04B | 31.22B | 29.45B | 25.02B |
| Asset Growth % | -16.19% | -0.93% | -7.23% | -3.81% | -16.38% | -4.57% | 8.06% | 8.8% | 2.32% | 5.7% | 9.78% | -1.26% | -1.27% | -7.47% | 12.78% | 15.04% | 20.13% | 6.02% | 20.55% | 10.03% | 6.11% | -5% | 16.41% | 13.11% | 19.01% | 1.69% | 0.51% | 18.64% | 6% | 17.72% | -1.25% |
| Total Investment Assets | 4M | 97.52B | 147.3B | 165.49B | 171.63B | 221B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 164.98B | 33.36B | 82.03B | 92.2B | 95.89B | 122.3B | -105.88B | -91.26B | -82.89B | -84.31B | -76.7B | -67.79B | -68.27B | -61.04B | -61.58B | -54.04B | -135M | -114M | -87M | -61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10M | -43.34M | -261.68M |
| Short-Term Investments | 87.53B | 64.15B | 65.27B | 73.29B | 75.74B | 98.7B | 105.88B | 91.26B | 82.89B | 84.31B | 76.7B | 67.79B | 68.27B | 61.04B | 61.58B | 54.04B | 135M | 114M | 87M | 61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10M | 43.34M | 261.68M |
| Total Current Assets | 104.22B | 71.95B | 0 | 0 | 0 | 0 | 111.82B | 96.99B | 88.08B | 88.63B | 82.23B | 72.85B | 73.77B | 64.75B | 64.59B | 56.97B | 2.92B | 3.2B | 1.95B | 2.36B | 1.74B | 1.88B | 4.23B | 1.6B | 1.81B | 1.19B | 909M | 886M | 656M | 495.02M | 488.68M |
| Cash & Equivalents | 6.12B | 6.25B | 6.23B | 4.31B | 3.94B | 5.05B | 5.14B | 4.9B | 4.34B | 3.49B | 4.86B | 4.35B | 4.66B | 2.54B | 2.04B | 2.25B | 2.12B | 2.32B | 941M | 1.56B | 1.2B | 1.3B | 3.81B | 1.05B | 1.38B | 852M | 609M | 616M | 374M | 235.68M | 0 |
| Receivables | 5.67B | 1.55B | 779M | 848M | 647M | 672M | 796M | 828M | 851M | 827M | 669M | 705M | 842M | 1.17B | 976M | 680M | 661M | 764M | 920M | 732M | 535M | 584M | 417M | 547M | 435M | 341M | 301M | 270M | 272M | 215.65M | 226.98M |
| Other Current Assets | 0 | 0 | -72.28B | -78.44B | -80.33B | -104.42B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 27.23B | 9.03B | 9.02B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.9M |
| Goodwill | 0 | 0 | 263M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 9.03B | 8.76B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60.9M |
| PP&E (Net) | 351M | 351M | 387M | 445M | 530M | 538M | 601M | 581M | 443M | 434M | 433M | 427M | 429M | 481M | 564M | 617M | 620M | 593M | 597M | 496M | 458M | 448M | 515M | 518M | 482M | 455M | 481M | 509M | 427M | 386.05M | 471.91M |
| Other Assets | 2.03B | 1.77B | -91.44B | -92.64B | -96.42B | -122.84B | 158.55B | 146.46B | 134.78B | 132.47B | 123.86B | 112.77B | 113.84B | 117.12B | 127.51B | 112.69B | 97.64B | 80.43B | 76.87B | 63.01B | 57.61B | 54.03B | 54.58B | 48.85B | 42.76B | 36.21B | 35.84B | 35.65B | 30.11B | 28.62B | 24.26B |
| Total Liabilities | 85.65B | 86.98B | 91.47B | 104.74B | 111.6B | 124.29B | 131.53B | 123.81B | 116.94B | 112.62B | 109.34B | 100.55B | 101.42B | 106.69B | 115.12B | 103.29B | 89.98B | 75.69B | 72.69B | 57.01B | 51.46B | 48.43B | 51.75B | 44.32B | 38.66B | 32.44B | 32.54B | 33.17B | 27.45B | 26.02B | 22.89B |
| Total Debt | 8.73B | 8.41B | 7.5B | 7.36B | 7.44B | 7.96B | 7.9B | 6.57B | 5.78B | 5.29B | 5.36B | 4.97B | 5.28B | 4.9B | 4.35B | 3.29B | 3.04B | 2.6B | 1.72B | 1.47B | 1.43B | 1.4B | 1.43B | 1.41B | 1.31B | 1.21B | 1.08B | 1.11B | 596M | 523.21M | 353.53M |
| Net Debt | 2.61B | 2.16B | 1.27B | 3.06B | 3.5B | 2.9B | 2.76B | 1.67B | 1.44B | 1.8B | 501M | 661M | 624M | 2.35B | 2.31B | 1.04B | 917M | 276M | 780M | -98M | 223M | 98M | -2.38B | 357M | -67M | 355M | 470M | 495M | 222M | 287.53M | 353.53M |
| Long-Term Debt | 8.73B | 8.33B | 7.4B | 7.24B | 7.29B | 7.84B | 7.75B | 6.41B | 5.76B | 4.72B | 4.69B | 4.95B | 4.97B | 4.89B | 4.34B | 3.27B | 3.04B | 2.6B | 1.72B | 2.27B | 1.43B | 1.4B | 1.43B | 1.41B | 1.31B | 1.21B | 1.08B | 1.02B | 596M | 516M | 336.1M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 548M | 649M | 0 | 300M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7M | 17.5M |
| Total Current Liabilities | 9.22B | 5.81B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 548M | 649M | 0 | 300M | 0 | 0 | 838M | 191M | 483M | 1.73B | 808M | 807M | 622M | 2.89B | 374M | 1.32B | 765M | 127M | 0 | 173M | 3.26B | 690.82M |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 838M | 191M | 483M | 1.73B | 732M | 807M | 622M | 2.89B | 374M | 1.32B | 765M | 127M | 0 | 173M | 3.25B | 673.32M |
| Deferred Revenue | 1.33B | 1.32B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 553M | 495M | -573M | -154M | -698M | -4.34B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 1.59B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 66.11B | 72.76B | -7.5B | -7.36B | -7.44B | -7.96B | 123.63B | 117.24B | 111.17B | 107.33B | 103.98B | 95.58B | 96.14B | 101.79B | 110.76B | 99.17B | 86.75B | 72.61B | 69.24B | 53.93B | 49.23B | 46.42B | 47.43B | 42.53B | 36.03B | 30.46B | 31.33B | 32.16B | 26.68B | 22.25B | 21.87B |
| Total Equity | 30.31B | 29.49B | 26.1B | 21.98B | 20.14B | 33.25B | 33.56B | 28.96B | 23.46B | 24.36B | 20.48B | 17.38B | 18.72B | 14.62B | 15.98B | 13.51B | 11.06B | 8.42B | 6.64B | 8.79B | 8.34B | 7.93B | 7.57B | 6.65B | 6.39B | 5.42B | 4.69B | 3.87B | 3.77B | 3.43B | 2.13B |
| Equity Growth % | 53.73% | 13% | 18.71% | 9.16% | -39.43% | -0.91% | 15.88% | 23.43% | -3.71% | 18.96% | 17.83% | -7.13% | 28.02% | -8.5% | 18.3% | 22.16% | 31.35% | 26.78% | -24.51% | 5.44% | 5.22% | 4.67% | 13.95% | 3.94% | 17.86% | 15.57% | 21.35% | 2.6% | 9.9% | 61.39% | -0.4% |
| Shareholders Equity | 30.31B | 29.49B | 26.1B | 21.98B | 20.14B | 33.25B | 33.56B | 28.96B | 23.46B | 24.36B | 20.48B | 17.38B | 18.72B | 14.62B | 15.98B | 13.51B | 11.06B | 8.42B | 6.64B | 8.79B | 8.34B | 7.93B | 7.57B | 6.65B | 6.39B | 5.42B | 4.69B | 3.87B | 3.77B | 3.43B | 2.13B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 56.22B | 54.68B | 52.28B | 47.99B | 44.37B | 41.38B | 37.98B | 34.29B | 31.79B | 29.89B | 25.98B | 24.01B | 22.16B | 19.89B | 17.39B | 15.58B | 14.19B | 12.41B | 11.31B | 10.64B | 9.3B | 8.05B | 6.99B | 5.88B | 5.24B | 4.54B | 3.96B | 3.36B | 2.86B | 2.44B | 1.92B |
| Common Stock | 136M | 136M | 136M | 136M | 135M | 135M | 135M | 135M | 135M | 67M | 67M | 67M | 67M | 67M | 67M | 66M | 66M | 66M | 66M | 66M | 66M | 65M | 65M | 65M | 65M | 65M | 32M | 32M | 32M | 15.82M | 15.72M |
| Accumulated OCI | 2.68B | 1.45B | -2.98B | -5.52B | -6.43B | 7.39B | 8.93B | 6.62B | 2.15B | 4.03B | 2.63B | 625M | 1.98B | -563M | 2.71B | 2.09B | 862M | 29M | -582M | 934M | 1.43B | 1.96B | 2.61B | 2.49B | 2.63B | 2.09B | 1.67B | 1.26B | 1.55B | 1.56B | 509.94M |
| Return on Equity (ROE) | 16.42% | 13.12% | 22.64% | 22.12% | 16.55% | 12.67% | 15.29% | 12.61% | 12.21% | 20.53% | 14.04% | 14.03% | 17.7% | 20.64% | 19.44% | 15.77% | 23.91% | 19.89% | 16.25% | 19.07% | 18.23% | 19.14% | 17.81% | 11.78% | 13.89% | 13.58% | 16.05% | 14.95% | 13.53% | 21.06% | 18.5% |
| Return on Assets (ROA) | 4.13% | 3.12% | 4.46% | 3.61% | 3.05% | 2.62% | 3.01% | 2.25% | 2.1% | 3.45% | 2.14% | 2.13% | 2.45% | 2.5% | 2.32% | 1.78% | 2.51% | 1.83% | 1.73% | 2.6% | 2.55% | 2.56% | 2.3% | 1.6% | 1.98% | 1.83% | 1.85% | 1.67% | 1.61% | 2.15% | 1.56% |
| Equity / Assets | 26.14% | 25.32% | 22.2% | 17.35% | 15.29% | 21.11% | 20.33% | 18.96% | 16.71% | 17.76% | 15.78% | 14.7% | 15.63% | 12.05% | 12.19% | 11.62% | 10.94% | 10.01% | 8.37% | 13.37% | 13.95% | 14.06% | 12.77% | 13.04% | 14.19% | 14.33% | 12.61% | 10.44% | 12.07% | 11.65% | 8.5% |
| Debt / Equity | 0.29x | 0.29x | 0.29x | 0.33x | 0.37x | 0.24x | 0.24x | 0.23x | 0.25x | 0.22x | 0.26x | 0.29x | 0.28x | 0.33x | 0.27x | 0.24x | 0.27x | 0.31x | 0.26x | 0.17x | 0.17x | 0.18x | 0.19x | 0.21x | 0.21x | 0.22x | 0.23x | 0.29x | 0.16x | 0.15x | 0.17x |
| Book Value per Share | 59.96 | 55.43 | 46.19 | 36.72 | 31.58 | 49.14 | 46.86 | 38.80 | 30.29 | 30.54 | 24.74 | 20.06 | 20.61 | 15.64 | 17.02 | 14.39 | 11.69 | 8.97 | 6.93 | 8.90 | 8.31 | 7.81 | 7.33 | 6.36 | 6.05 | 5.05 | 4.31 | 3.51 | 3.42 | 3.05 | 1.83 |
| Tangible BV per Share | 59.96 | 38.45 | 30.22 | 36.72 | 31.58 | 49.14 | 46.86 | 38.80 | 30.29 | 30.54 | 24.74 | 20.06 | 20.61 | 15.64 | 17.02 | 14.39 | 11.69 | 8.97 | 6.93 | 8.90 | 8.31 | 7.81 | 7.33 | 6.36 | 6.05 | 5.05 | 4.31 | 3.51 | 3.42 | 3.05 | 1.78 |
Quick answers to the most common questions about buying AFL stock.
As of 2025, Aflac Incorporated (AFL) had total assets of $116.47B including $71.95B in current assets.
Aflac Incorporated (AFL) carries total debt of $8.41B, offset by $70.40B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Aflac Incorporated (AFL) has total shareholders' equity (book value) of $29.49B ($55.43 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Aflac Incorporated (AFL) reported a current ratio of 12.39x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Asset base shrinkage amid Yen headwinds
Metrics are mathematically derived from official filings.
Capital Base Contracts as Asset Runoff Continues
Aflac's total assets have contracted by over $12 billion from their 2025Q2 peak, falling to $116.0 billion in 2026Q2, while policyholder equity has expanded to $30.3 billion, suggesting a managed runoff of liabilities may be strengthening the equity cushion despite top-line pressure.
The trajectory of the balance sheet points toward a deliberate de-risking, with the equity base growing 11.7% from its 2024Q1 low even as total liabilities shrank by $15.6 billion. This pattern is consistent with a life insurer managing a legacy book or reacting to currency-adjusted asset revaluations, rather than one in a phase of active growth. The key question for investors is whether this equity accretion is driven by genuine operating capital generation or by accounting adjustments that may not reflect underlying economic strength.
Obscured Portfolio Faces Valuation Uncertainty
The reported invested asset base of $1,000.0 thousand for ten consecutive quarters appears to be a data reporting anomaly, masking the true scale and quality of Aflac's multi-billion-dollar fixed-income and alternative portfolio that is central to its earnings power.
The consistent, nominal investment figure is inconsistent with the company's disclosed asset-liability structure and prior filings, preventing a meaningful analysis of portfolio duration, credit quality, or unrealized loss position. For a life insurer of this scale, the investment portfolio is the primary engine of spread earnings, and its composition is critical to assessing interest rate sensitivity and reserve adequacy. Until accurate data is available, analysts must rely on management commentary regarding asset allocation and capital deployment, which warrants significant scrutiny.
Erratic Loss Ratio Volatility Undermines Reserve Confidence
The loss ratio has exhibited extreme volatility, ranging from a benign 40.1% to an alarming 85.8% within six quarters, a pattern that, as noted in prior analysis, strongly suggests the use of prior-period reserve adjustments to smooth current earnings rather than reflecting consistent underwriting performance.
The wild swings in the loss ratio are not characteristic of a stable supplemental health business and indicate that reported claims are being heavily influenced by management's assumptions and reserve modeling. The spike to 85.8% in 2025Q1 followed by an immediate improvement suggests potential one-time charges or adverse development that was later reversed, creating significant noise in the underlying trend. This volatility makes it difficult to assess the true embedded risk in the policyholder reserves and their sufficiency for future claims.
Equity Growth Provides Buffers, But Signals Runoff
Despite a shrinking asset base, Aflac's equity has steadily improved to $30.3 billion, yielding a debt-to-equity ratio of approximately 0.29%, which appears to provide ample statutory capital buffers but may reflect the absence of deployment opportunities rather than proactive capital generation.
The improving equity position is a positive credit signal, suggesting the company is retaining earnings and managing its capital structure conservatively. However, the concurrent decline in total assets and liabilities indicates this is likely a defensive posture during a period of top-line contraction and currency translation headwinds. Management's capacity for buybacks or M&A is therefore likely constrained by the need to maintain capital ratios in a low-growth environment, rather than being limited by a lack of financial flexibility.
Legacy Yen Exposure and Reserve Assumptions
The most significant non-obvious risk appears to be the interaction between a weakening Yen and Aflac's reserve assumptions, where translated asset values may be eroding faster than liability valuations, potentially pressuring solvency margins in ways not fully visible in U.S. dollar-reported equity figures.
Given that over 70% of earnings originate from Japan, the balance sheet's U.S. dollar strength is highly dependent on the exchange rate. A sustained Yen depreciation could reduce the U.S. dollar value of Japanese assets backing local-currency reserves, creating a mismatch if liability discount rates or claim cost assumptions are not adjusted commensurately. This currency-driven erosion of the economic surplus is distinct from accounting volatility and represents a fundamental risk to the company's long-term capital adequacy, warranting close monitoring of both FX rates and management's hedging disclosure.